Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials Blog 基于模型的荟萃分析(MBMA)在 GSK 的应用:对战略和临床试验的实际影响 GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…Certara2025 年 7 月 31 日
Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development Case Study 杜氏肌营养不良症(DMD)药物研发中的剂量优化与监管结果优化 Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.Certara2025 年 7 月 29 日
Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling On-Demand Webinar 无动物实验的洞察:利用人源化芯片与 PBPK 建模 Certara2025 年 7 月 29 日
MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines On-Demand Webinar MIDD 策略在临床前和临床转化中的应用:临床药理学家与建模学科的合作 Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.Certara2025 年 7 月 29 日
ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered Blog ADNCA 解析:下一代非房室分析及其核心问题解答 ADNCA is transforming non-compartmental analysis by standardizing workflows, enhancing regulatory confidence, and enabling scalable automation.…Certara2025 年 7 月 23 日
Streamline Your Regulatory Writing with Process Infographics Press Coverage 流程信息图助您优化监管写作 Discover how process infographics successfully enhance regulatory writing by simplifying complex workflows, improving compliance documentation,…Certara2025 年 7 月 17 日
MIDD can ease pediatric & rare disease drug loss in Japan Blog MIDD 可缓解日本儿科及罕见疾病药物短缺问题 Certara tackles pediatric cancer and rare disease drug loss in Japan by advocating MIDD, which…Certara2025 年 7 月 8 日
Accelerating Oncology Drug FDA RTOR Submission with Project Management Services Case Study 通过项目管理服务加速肿瘤药物 FDA RTOR 申报流程 Discover how Certara’s dedicated project management and pharmacometric support helped an emerging biotech company fast-track…Certara2025 年 7 月 2 日
The Medicine Maker: The Biosimulation Generation Press Coverage 药物制造者:生物模拟时代 The article, The Biosimulation Generation, explores the transformative potential of biosimulation in pharmaceutical R&D as…Danielle Pillsbury2025 年 7 月 1 日
5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address Blog 5 大临床开发挑战 — 基于模型的荟萃分析(MBMA)助力应对 2025 年 6 月 30 日 Drug development is increasingly defined by its complexity. Teams must navigate rising…Certara2025 年 6 月 30 日